Furthermore, pharmacological inhibition of AIG1 reversed obesity-induced insulin resistance and restored glucose homeostasis in the setting of adipocyte IRF3 overexpression. Here, AIG1 is linked to obesity due to melanocortin 4 receptor deficiency.